-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Tq/PwXM1rFDB8qmiWuTrAoQUCSvu7qtqeoNtYkmmrfZOvVV7GxmASC1P6mGVZLPr CHOrIjUdt/TE8t8OEAB6ww== 0000950130-97-001652.txt : 19970414 0000950130-97-001652.hdr.sgml : 19970414 ACCESSION NUMBER: 0000950130-97-001652 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 19970410 ITEM INFORMATION: Other events FILED AS OF DATE: 19970411 SROS: NASD FILER: COMPANY DATA: COMPANY CONFORMED NAME: ROBERTS PHARMACEUTICAL CORP CENTRAL INDEX KEY: 0000853022 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 222429994 STATE OF INCORPORATION: NJ FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-19173 FILM NUMBER: 97578544 BUSINESS ADDRESS: STREET 1: MERIDIAN CENTRE II STREET 2: 4 INDUSTRIAL WAY W CITY: EATONTOWN STATE: NJ ZIP: 07724 BUSINESS PHONE: 9083891182 MAIL ADDRESS: STREET 1: MERIDIAN CTR II STREET 2: 4 INDUSTRIAL WAY WEST CITY: EATONTOWN STATE: NJ ZIP: 07724 8-K 1 FORM 8-K FORM 8-K SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 10, 1997 ROBERTS PHARMACEUTICAL CORPORATION - -------------------------------------------------------------------------------- (exact name of registrant as specified in its charter) NEW JERSEY 1-1-432 22-2429994 ---------------------- ---------------- --------------- (State or other (Commission (IRS Employer jurisdiction of File Number Identification incorporation) Number) Meridian Center II 4 Industrial Way West Eatontown, New Jersey 07724 - -------------------------------------------------------------------------------- (Address of principal executive offices, including zip code) Registrant's telephone number, including area code: 908-389-1182 Meridian Center II 4 Industrial Way West Eatontown, New Jersey 07724 - -------------------------------------------------------------------------------- (Former name or former address, if changed from last report) - 2 - Item 5. Other Events ------------ Roberts Pharmaceutical Corporation announced that David S. Tierney, M.D., formerly of Elan Pharmaceutical Research Corporation, has joined Roberts as Senior Vice President, Medical and Regulatory Affairs. In this newly created position, Dr. Tierney will assume overall responsibility for the drug development program at Roberts which, in recent months, has been significantly expanded with the addition of compounds licensed from Lilly and Pfizer that address potentially large markets. Before joining Roberts, Dr. Tierney held senior positions with Elan Pharmaceutical Research where his responsibilities included global clinical development of new compounds in several different therapeutic categories. Most recently he served Elan Pharmaceutical Research as Head of Worldwide Clinical Research and prior to that as Director of Medical Affairs. Dr. Tierney is a graduate of the Medical School of the Royal College of Surgeons, Dublin, Ireland. The Company commented that Dr. Tierney possesses an abundance of experience in pharmaceutical product development and his background and experiences should strongly augment Roberts existing staff of professionals and the Company's commitment to bringing new products through development into the market. SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. ROBERTS PHARMACEUTICAL CORPORATION ---------------------------------- (Registrant) Date: April 11, 1997 By: /s/ Anthony A. Rascio --------------------- Anthony A. Rascio Vice President -----END PRIVACY-ENHANCED MESSAGE-----